Drug Shortage Report for ACZONE

Last updated on 2022-08-03 History
Report ID 156850
Drug Identification Number 02281074
Brand name ACZONE
Common or Proper name ACZONE
Company Name BAUSCH HEALTH, CANADA INC.
Market Status MARKETED
Active Ingredient(s) DAPSONE
Strength(s) 5%
Dosage form(s) GEL
Route of administration TOPICAL TOPICAL
Packaging size 60g
ATC code D10AX
ATC description ANTI-ACNE PREPARATIONS FOR TOPICAL USE
Reason for shortage Other (Please describe in comments)
Anticipated start date 2022-05-17
Actual start date 2022-05-18
Estimated end date 2022-07-29
Actual end date 2022-08-01
Shortage status Resolved
Updated date 2022-08-03
Company comments production delay
Health Canada comments
Tier 3 Status No
Contact Address 2150 BOUL. ST-ELZEAR OUEST
LAVAL, QUEBEC
CANADA H7L 4A8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v17 2022-08-03 French Compare
v16 2022-08-03 English Compare
v15 2022-06-29 French Compare
v14 2022-06-29 English Compare
v13 2022-06-15 French Compare
v12 2022-06-15 English Compare
v11 2022-06-02 French Compare
v10 2022-06-02 English Compare
v9 2022-05-18 English Compare
v8 2022-05-11 French Compare
v7 2022-05-11 English Compare
v6 2022-05-04 English Compare
v5 2022-04-28 French Compare
v4 2022-04-28 English Compare
v3 2022-04-27 English Compare
v2 2022-03-17 French Compare
v1 2022-03-17 English Compare

Showing 1 to 17 of 17